Skip to main content

Table 4 Geographic variation in considering cytoplasmic ANA IIF patterns as ANA positive

From: Current laboratory and clinical practices in reporting and interpreting anti-nuclear antibody indirect immunofluorescence (ANA IIF) patterns: results of an international survey

a) The results are presented as absolute numbers and in percentage (%) of the responders per geographic continent

 

Total

Competent

Expert

Continent

n

Reporting (%)

n

Reporting (%)

n

Reporting (%)

Africa

5

3 (60.0%)

4

2 (50.0%)

1

1 (100.0%)

Asia

48

32 (66.7%)

26

16 (61.5%)

22

16 (72.7%)

Australia

5

0 (0.0%)

1

0 (0.0%)

4

0 (0.0%)

Europe

211

102 (48.3%)

98

40 (40.8%)

113

62 (54.9%)

North Amercia

28

18 (64.3%)

12

6 (50.0%)

16

12 (75%)

South America

49

32 (65.3%)

23

12 (52.2%)

26

20 (76.9%)

Total

346a

187 (54.1%)

164

76 (46.3%)

182

111 (61.0%)

b) The results are presented as percentage (%) of the total responders per participating European country

 

Total

Competent

Expert

Country

n

ANA positive (%)

n

ANA positive (%)

n

ANA positive (%)

Austria

13

2 (15.4%)

3

0 (0.0%)

10

2 (20.0%)

Belgium

34

22 (64.7%)

25

13 (52%)

9

9 (100.0%)

Bosnia and Herzegovina

1

1 (100.0%)

1

1 (100.0%)

n.a

n.a

Bulgaria

1

0 (0.0%)

n.a

n.a

1

0 (0.0%)

Croatia

6

3 (50.0%)

2

1 (50.0%)

4

2 (50.0%)

Czech Republic

1

0 (0.0%)

1

0 (0.0%)

n.a

n.a

Denmark

1

0 (0.0%)

1

0 (0.0%)

n.a

n.a

Estonia

5

5 (100.0%)

2

2 (100.0%)

3

3 (100.0%)

Finland

4

2 (50.0%)

2

1 (50.0%)

2

1 (50.0%)

France

7

4 (57.1%)

4

2 (50.0%)

3

2 (66.7%)

Germany

1

0 (0.0%)

n.a

n.a

1

0 (0.0%)

Greece

7

3 (42.9%)

2

1 (50.0%)

5

2 (40.0%)

Hungary

3

0 (0.0%)

n.a

n.a

3

0 (0.0%)

Italy

18

11 (61.1%)

5

2 (40.0%)

13

9 (69.2%)

Kazakhstan

2

2 (100.0%)

2

2 (100.0%)

n.a

n.a

Malta

1

1 (100.0%)

n.a

n.a

1

1 (100%)

Netherlands

25

3 (12.0%)

20

2 (10.0%)

5

1 (20.0%)

Norway

1

0 (0.0%)

n.a

n.a

1

0 (0.0%)

Poland

3

2 (66.7%)

n.a

n.a

3

2 (66.7%)

Portugal

23

18 (78.3%)

8

6 (75.0%)

15

12 (80.0%)

Romania

2

2 (100.0%)

n.a

n.a

2

2 (100.0%)

Serbia

1

0 (0.0%)

1

0 (0.0%)

n.a

n.a

Slovakia

1

1 (100.0%)

n.a

n.a

1

1 (100.0%)

Spain

21

14 (66.7%)

8

5 (62.5%)

13

9 (69.2%)

Sweden

8

1 (12.5%)

1

0 (0.0%)

7

1 (14.3%)

Switzerland

7

2 (28.6%)

n.a

n.a

7

2 (28.6%)

Turkey

5

1 (20.0%)

2

1 (50.0%)

3

0 (0.0%)

United Kingdom

9

2 (22.2%)

9

2 (22.2%)

0

0 (0.0%)

Total

211

102 (48.3%)

99

41 (41.4%)

112

61 (54.5%)

  1. an = 6 laboratories reported expertise level ‘not applicable’ and n = 1 no country